$AADI
Aadi Bioscience, Inc.

2021 Q3 Form 10-Q Financial Statement

#000156459021055958 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q4 2020 Q3
Revenue $0.00 $14.00M $231.0K
YoY Change -100.0%
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $7.401M $2.405M $500.0K
YoY Change 1380.2% 56.19% -76.85%
% of Gross Profit
Research & Development $5.754M $3.230M $2.400M
YoY Change 139.75% 51.64% -15.63%
% of Gross Profit
Depreciation & Amortization $4.550K $54.48K -$23.17K
YoY Change -119.64% 81.6% -215.85%
% of Gross Profit
Operating Expenses $87.31M $5.637M $2.894M
YoY Change 2916.97% 21.03% -41.73%
Operating Profit -$87.31M -$2.663M
YoY Change 3178.67% -46.38%
Interest Expense $157.0K $2.360K $229.0K
YoY Change -31.44% -98.61% -4.35%
% of Operating Profit
Other Income/Expense, Net $223.0K $916.6K -$228.0K
YoY Change -197.81% 334.22% -171.54%
Pretax Income -$87.09M -$4.718M -$2.891M
YoY Change 2912.38% 6.02% -37.83%
Income Tax $0.00 $1.000K
% Of Pretax Income
Net Earnings -$87.10M -$4.718M -$2.892M
YoY Change 2911.76% 6.02% -37.78%
Net Earnings / Revenue -33.7% -1251.95%
Basic Earnings Per Share -$9.17
Diluted Earnings Per Share -$9.157M -$1.500M -$1.14
COMMON SHARES
Basic Shares Outstanding 9.510M shares
Diluted Shares Outstanding 9.510M shares

Balance Sheet

Concept 2021 Q3 2020 Q4 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $161.4M $42.60M $47.28M
YoY Change 241.3% 10.66% 8.94%
Cash & Equivalents $161.4M $4.455M $7.730M
Short-Term Investments
Other Short-Term Assets $643.0K $1.604M $2.301M
YoY Change -72.06% 118.28% 162.56%
Inventory
Prepaid Expenses $510.2K
Receivables $0.00 $14.15M
Other Receivables $0.00
Total Short-Term Assets $162.0M $18.69M $49.58M
YoY Change 226.76% -52.78% 10.67%
LONG-TERM ASSETS
Property, Plant & Equipment $14.00K $21.00K $227.1K
YoY Change -93.84% -87.21% -19.39%
Goodwill
YoY Change
Intangibles $3.880M
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.263M $20.00K $20.00K
YoY Change 11215.0%
Total Long-Term Assets $6.754M $140.0K $247.1K
YoY Change 2633.42% -61.78% -66.94%
TOTAL ASSETS
Total Short-Term Assets $162.0M $18.69M $49.58M
Total Long-Term Assets $6.754M $140.0K $247.1K
Total Assets $168.8M $18.83M $49.83M
YoY Change 238.69% -52.86% 9.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.205M $2.392M $709.3K
YoY Change 633.85% 443.9% -5.56%
Accrued Expenses $6.250M $4.099M $1.803M
YoY Change 246.7% 41.34% -37.84%
Deferred Revenue
YoY Change
Short-Term Debt $22.00K $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.57M $30.06M $2.512M
YoY Change 360.48% 801.56% -30.25%
LONG-TERM LIABILITIES
Long-Term Debt $5.757M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $523.0K $97.00K
YoY Change -3.0%
Total Long-Term Liabilities $6.280M $97.00K $0.00
YoY Change -3.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.57M $30.06M $2.512M
Total Long-Term Liabilities $6.280M $97.00K $0.00
Total Liabilities $17.85M $31.26M $2.512M
YoY Change 610.48% 818.93% -34.54%
SHAREHOLDERS EQUITY
Retained Earnings -$126.7M -$32.60M
YoY Change -77.08%
Common Stock $277.6M $20.16M
YoY Change -88.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $150.9M -$12.43M -$20.49M
YoY Change
Total Liabilities & Shareholders Equity $168.8M $18.83M $49.83M
YoY Change 238.69% -52.86% 9.39%

Cashflow Statement

Concept 2021 Q3 2020 Q4 2020 Q3
OPERATING ACTIVITIES
Net Income -$87.10M -$4.718M -$2.892M
YoY Change 2911.76% 6.02% -37.78%
Depreciation, Depletion And Amortization $4.550K $54.48K -$23.17K
YoY Change -119.64% 81.6% -215.85%
Cash From Operating Activities -$4.101M $4.041M -$15.78M
YoY Change -74.01% -183.15% 230.77%
INVESTING ACTIVITIES
Capital Expenditures -$19.03K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $25.20M $0.00
YoY Change
Cash From Investing Activities $25.20M -$19.03K $12.20K
YoY Change 206449.18% -222.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $155.0M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 141.6M 8.290M 1.194M
YoY Change 11760.24%
NET CHANGE
Cash From Operating Activities -4.101M 4.041M -15.78M
Cash From Investing Activities 25.20M -19.03K 12.20K
Cash From Financing Activities 141.6M 8.290M 1.194M
Net Change In Cash 162.7M 12.31M -14.57M
YoY Change -1216.6% -353.34% 204.85%
FREE CASH FLOW
Cash From Operating Activities -$4.101M $4.041M -$15.78M
Capital Expenditures -$19.03K
Free Cash Flow $4.060M
YoY Change -183.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
-11498000
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P3Y5M1D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M3D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M17D
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P3Y5M15D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0115
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0115
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0080
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.8727
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.8788
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.9252
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0084
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0084
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0034
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.8602
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.8521
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.8957
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Information Former Legal Or Registered Name
EntityInformationFormerLegalOrRegisteredName
Aerpio Pharmaceuticals, Inc.
dei Security12b Title
Security12bTitle
Common stock, $0.0001 par value per share
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161375000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14149000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
643000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
162018000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
597000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3880000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2263000
CY2021Q3 us-gaap Assets
Assets
168772000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5205000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6250000
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
22000
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
9029000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
90000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
99000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11567000
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1102000
CY2021Q3 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
5757000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
523000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
97000
CY2021Q3 us-gaap Liabilities
Liabilities
17847000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20883454
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20883454
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
277618000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-126695000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
150925000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
168772000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
120000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5754000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9684000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
499000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8793000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1700000
CY2021Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
74156000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
74156000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
87311000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
2894000
us-gaap Operating Expenses
OperatingExpenses
95392000
us-gaap Operating Expenses
OperatingExpenses
11384000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-87311000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2663000
us-gaap Operating Income Loss
OperatingIncomeLoss
-95272000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10953000
CY2021Q3 aadi Change In Fair Value Of Convertible Promissory Notes
ChangeInFairValueOfConvertiblePromissoryNotes
-380000
aadi Change In Fair Value Of Convertible Promissory Notes
ChangeInFairValueOfConvertiblePromissoryNotes
-1585000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
196000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
us-gaap Investment Income Interest
InvestmentIncomeInterest
41000
CY2021Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
142000
CY2020Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
204000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
542000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
531000
CY2021Q3 us-gaap Interest Expense
InterestExpense
157000
CY2020Q3 us-gaap Interest Expense
InterestExpense
229000
us-gaap Interest Expense
InterestExpense
608000
us-gaap Interest Expense
InterestExpense
585000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
223000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-228000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1174000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-544000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-87088000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2891000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-94098000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11497000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-87088000
us-gaap Net Income Loss
NetIncomeLoss
-94100000
CY2021Q3 aadi Cumulative Dividends On Convertible Preferred Stock
CumulativeDividendsOnConvertiblePreferredStock
154000
CY2020Q3 aadi Cumulative Dividends On Convertible Preferred Stock
CumulativeDividendsOnConvertiblePreferredStock
247000
aadi Cumulative Dividends On Convertible Preferred Stock
CumulativeDividendsOnConvertiblePreferredStock
647000
aadi Cumulative Dividends On Convertible Preferred Stock
CumulativeDividendsOnConvertiblePreferredStock
740000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-87242000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3139000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-94747000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12238000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-9.17
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.23
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-19.37
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.81
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9510379
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2542358
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4890556
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2542358
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-12432000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5476000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-17872000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-19369000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
745000
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-1000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
648000
CY2021Q3 aadi Cumulative Dividends Paid On Series A Preferred Stock
CumulativeDividendsPaidOnSeriesAPreferredStock
4412000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-87088000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
150925000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-9093000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3324000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-12388000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5282000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-17633000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2892000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-20491000
us-gaap Net Income Loss
NetIncomeLoss
-94100000
us-gaap Net Income Loss
NetIncomeLoss
-11498000
aadi Impairment Of Acquired Contract Intangible Asset
ImpairmentOfAcquiredContractIntangibleAsset
74156000
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
135000
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
aadi Change In Fair Value Of Convertible Promissory Notes
ChangeInFairValueOfConvertiblePromissoryNotes
-1585000
us-gaap Related Party Costs
RelatedPartyCosts
542000
us-gaap Related Party Costs
RelatedPartyCosts
531000
aadi Non Cash Interest Expense
NonCashInterestExpense
584000
aadi Non Cash Interest Expense
NonCashInterestExpense
585000
aadi Gain On Forgiveness Of Payroll Protection Plan Loan
GainOnForgivenessOfPayrollProtectionPlanLoan
196000
us-gaap Share Based Compensation
ShareBasedCompensation
723000
us-gaap Share Based Compensation
ShareBasedCompensation
100000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
133000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
124000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-14149000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-54000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
526000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
37000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-430000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-121000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-146000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4860000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1611000
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-8535000
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-226000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9995000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9426000
aadi Cash Acquired In Connection With Merger
CashAcquiredInConnectionWithMerger
29700000
aadi Transaction Expenses Related To Merger
TransactionExpensesRelatedToMerger
4501000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25199000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
745000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
9617000
us-gaap Payments Of Dividends
PaymentsOfDividends
4412000
aadi Proceeds From Issuance Of Convertible Promissory Notes
ProceedsFromIssuanceOfConvertiblePromissoryNotes
1000000
aadi Proceeds From Payroll Protection Loan Program
ProceedsFromPayrollProtectionLoanProgram
194000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
141716000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1194000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
156920000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8232000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4455000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15962000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161375000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7730000
aadi Issuance Of Common Stock Upon Merger
IssuanceOfCommonStockUponMerger
105888000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
610000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
9130000
CY2021Q3 aadi Anniversary Period Of Closing Of Merger Agreement
AnniversaryPeriodOfClosingOfMergerAgreement
P20Y
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-126700000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-87100000
us-gaap Net Income Loss
NetIncomeLoss
-94100000
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
155000000.0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
155000000.0
CY2021Q3 aadi Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
145400000
aadi Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
145400000
aadi Cash Acquired In Connection With Merger
CashAcquiredInConnectionWithMerger
29700000
aadi Cash Acquired In Connection With Merger Net
CashAcquiredInConnectionWithMergerNet
27700000
aadi Cash Acquired In Connection With Merger After Compensation Expenses
CashAcquiredInConnectionWithMergerAfterCompensationExpenses
2000000.0
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161400000
CY2021Q3 us-gaap Shares Outstanding
SharesOutstanding
8100000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2500000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000.0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
No fractional shares were issued in connection with the Reverse Stock Split.
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:6pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that impact the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities in the Company’s financial statements and accompanying notes. In the opinion of management, all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation </p> <p style="margin-bottom:6pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">have been included.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The most significant estimates in the Company’s condensed consolidated financial statements relate to stock-based compensation expense and accrued research and development costs.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, actual results may materially differ from these estimates and assumptions. </span></p>
CY2021Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
273000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
273000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
273000
CY2021Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0
CY2021Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
390949
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.00
CY2021Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0
us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P14Y3M18D
CY2021Q3 aadi Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
2720000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3880000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
505000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
727620
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
26.58
aadi Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Assumed Through Merger
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodAssumedThroughMerger
248258
aadi Share Based Compensation Arrangements By Share Based Payment Award Options Assumed Through Merger In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedThroughMergerInPeriodWeightedAverageExercisePrice
29.20
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
61075
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
7306
CY2020Q1 aadi Convertible Notes Interest Rate For Fourth Month Date Of Loan Agreement
ConvertibleNotesInterestRateForFourthMonthDateOfLoanAgreement
0.06
CY2019Q4 aadi Convertible Notes Interest Rate For Fifth And Sixth Month Date Of Loan Agreement
ConvertibleNotesInterestRateForFifthAndSixthMonthDateOfLoanAgreement
0.08
CY2020Q1 aadi Convertible Notes Interest Rate For Fifth And Sixth Month Date Of Loan Agreement
ConvertibleNotesInterestRateForFifthAndSixthMonthDateOfLoanAgreement
0.08
CY2019Q4 aadi Convertible Notes Interest Rate For Remaining Sixth Months Term Until Maturity At Twelve Months
ConvertibleNotesInterestRateForRemainingSixthMonthsTermUntilMaturityAtTwelveMonths
0.10
CY2020Q1 aadi Convertible Notes Interest Rate For Remaining Sixth Months Term Until Maturity At Twelve Months
ConvertibleNotesInterestRateForRemainingSixthMonthsTermUntilMaturityAtTwelveMonths
0.10
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
25000000.0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
74200000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3900000
aadi Percentage Of Future Net Cash Proceeds Will Be Remitted To Contingent Value Rights Holders
PercentageOfFutureNetCashProceedsWillBeRemittedToContingentValueRightsHolders
0.90
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P14Y3M18D
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3906000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
26000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3880000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
68000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
273000
CY2021Q3 aadi Convertible Notes Interest Rate For Fourth Month Date Of Loan Agreement
ConvertibleNotesInterestRateForFourthMonthDateOfLoanAgreement
0.80
aadi Convertible Notes Interest Rate In Five Or Six Months
ConvertibleNotesInterestRateInFiveOrSixMonths
0.75
aadi Convertible Notes Interest Rate Later Than Six Months
ConvertibleNotesInterestRateLaterThanSixMonths
0.70
aadi Outstanding Principal Percentage To Be Prepaid Within Four Months
OutstandingPrincipalPercentageToBePrepaidWithinFourMonths
1.20
aadi Outstanding Principal Percentage To Be Prepaid Within Fifth And Sixth Months
OutstandingPrincipalPercentageToBePrepaidWithinFifthAndSixthMonths
1.30
CY2021Q3 aadi Accrued Clinical Current
AccruedClinicalCurrent
2367000
CY2020Q4 aadi Accrued Clinical Current
AccruedClinicalCurrent
2017000
CY2021Q3 aadi Accrued Contract Manufacturing Current
AccruedContractManufacturingCurrent
1793000
CY2020Q4 aadi Accrued Contract Manufacturing Current
AccruedContractManufacturingCurrent
1301000
CY2021Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
563000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
597000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1527000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
184000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6250000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4099000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
597000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
119000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
90000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
125000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
523000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
613000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
125000
aadi Outstanding Principal Percentage To Be Prepaid After Sixth Month But Prior To Maturity
OutstandingPrincipalPercentageToBePrepaidAfterSixthMonthButPriorToMaturity
1.40
us-gaap Troubled Debt Restructuring Debtor Current Period Description Of Changes In Terms
TroubledDebtRestructuringDebtorCurrentPeriodDescriptionOfChangesInTerms
Private Aadi entered into an amendment to the October 2019 and January 2020 Convertible Notes, whereby the term was extended from one year to two years
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20883454
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2542358
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2558218
CY2021Q3 aadi Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
145400000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
4.80
CY2021Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
698018
CY2021Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
9500000
CY2021Q3 aadi Gains Losses On Conversion Of Convertible Notes
GainsLossesOnConversionOfConvertibleNotes
400000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
178000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
231000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
238000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
40000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
696000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
83000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
613000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
90000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
523000
CY2021Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0680
aadi Right To Terminate License Agreement
RightToTerminateLicenseAgreement
P120D
aadi Upfront Payment For License Agreement
UpfrontPaymentForLicenseAgreement
14000000.0
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14000000.0
CY2021Q1 aadi Upfront Payment For License Agreement
UpfrontPaymentForLicenseAgreement
14000000.0
aadi Amount Of Certain Development Regulatory And Sales Milestones Payments Eligible To Receive Under License Agreement
AmountOfCertainDevelopmentRegulatoryAndSalesMilestonesPaymentsEligibleToReceiveUnderLicenseAgreement
257000000.0
CY2019Q4 aadi Proceeds From Issuance Of Convertible Notes
ProceedsFromIssuanceOfConvertibleNotes
8100000
CY2020Q1 aadi Proceeds From Issuance Of Convertible Notes
ProceedsFromIssuanceOfConvertibleNotes
1000000.0
CY2019Q4 aadi Convertible Notes Interest Rate For Fourth Month Date Of Loan Agreement
ConvertibleNotesInterestRateForFourthMonthDateOfLoanAgreement
0.06
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
36.47
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1298446
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.33
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13156000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
493890
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
13.79
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
9646000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
669731
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
727620
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
53131
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
648000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
34000
us-gaap Share Based Compensation
ShareBasedCompensation
723000
us-gaap Share Based Compensation
ShareBasedCompensation
100000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
300000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
19.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.57
aadi Number Of Class Of Warrants Exercised
NumberOfClassOfWarrantsExercised
3334
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
36666
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2019Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
40000
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.29
aadi Class Of Warrant Or Right Expiration Date
ClassOfWarrantOrRightExpirationDate
2024-10-24
CY2021Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0

Files In Submission

Name View Source Status
0001564590-21-055958-index-headers.html Edgar Link pending
0001564590-21-055958-index.html Edgar Link pending
0001564590-21-055958.txt Edgar Link pending
0001564590-21-055958-xbrl.zip Edgar Link pending
aadi-10q_20210930.htm Edgar Link pending
aadi-10q_20210930_htm.xml Edgar Link completed
aadi-20210930.xsd Edgar Link pending
aadi-20210930_cal.xml Edgar Link unprocessable
aadi-20210930_def.xml Edgar Link unprocessable
aadi-20210930_lab.xml Edgar Link unprocessable
aadi-20210930_pre.xml Edgar Link unprocessable
aadi-ex1013_331.htm Edgar Link pending
aadi-ex1014_329.htm Edgar Link pending
aadi-ex1015_224.htm Edgar Link pending
aadi-ex1017_330.htm Edgar Link pending
aadi-ex1018_332.htm Edgar Link pending
aadi-ex311_9.htm Edgar Link pending
aadi-ex312_8.htm Edgar Link pending
aadi-ex321_6.htm Edgar Link pending
aadi-ex322_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ga21htwinnk5000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending